The MEF2B gene is mutated in ∼11% of DLBCLs and ∼12% of FL, resulting in enhanced transcriptional activity, increased BCL6 expression, and increased proliferation of DLBCL cell lines (Figure 1D; Ying et al., 2013). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.